Acetohexamide

CAS No. 968-81-0

Acetohexamide( Acetohexamide | Dymelor | Gamadiabet | Acetohexamid | Dimelin | Dimelor )

Catalog No. M16874 CAS No. 968-81-0

Acetohexamide is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 26 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Acetohexamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Acetohexamide is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2.
  • Description
    Acetohexamide is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2; stimulate the pancreas to secrete insulin.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Acetohexamide | Dymelor | Gamadiabet | Acetohexamid | Dimelin | Dimelor
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    NADPH
  • Recptor
    NADPH| Potassium Channel
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    968-81-0
  • Formula Weight
    324.4
  • Molecular Formula
    C15H20N2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: > 10 mM
  • SMILES
    CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2
  • Chemical Name
    1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Aldawsari H, et al. Int J Pharm. 2013 Sep 10;453(2):315-2
molnova catalog
related products
  • NecroX-7 B

    NecroX-7 (LC-280126) is a potent free radical scavenger and HMGB1 (high-mobility group box 1) inhibitor.

  • Quercetin-3-O-glucos...

    Quercetin-3-O-glucose-6''-acetate is an inhibitor of NADPH oxidase. Quercetin-3-O-glucose-6''-acetate has antioxidant activities.

  • PTC-209 HBr

    PTC-209 HBr is the hydrobromide salt of PTC-209, which is a potent and selective BMI-1 inhibitor with IC50 of 0.5 μM, and results in irreversible reduction of cancer-initiating cells (CICs).